Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Show other versions (1)

Bibliographic Details
Main Authors:	Nazarzadeh, M, Pinho-Gomes, A, Bidel, Z, Canoy, D, Dehghan, A, Byrne, KS, Bennett, D, Smith, GD, Rahimi, K
Format:	Conference item
Language:	English
Published:	Oxford University Press 2020

Similar Items

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation
by: Nazarzadeh, M, et al.
Published: (2021)

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation: a Mendelian randomization study
by: Nazarzadeh Larzjan, M, et al.
Published: (2021)

Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies
by: Nazarzadeh, M, et al.
Published: (2022)

Blood pressure treatment: how low should you go? – Authors' reply
by: Rahimi, K, et al.
Published: (2021)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis
by: Pinho-Gomes, A-C, et al.
Published: (2021)

Management of blood pressure in atrial fibrillation, heart failure and multimorbidity
by: Pinho-Gomes, AC
Published: (2020)

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials
by: Pinho-Gomes, A, et al.
Published: (2019)

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?
by: Canoy, D, et al.
Published: (2022)

Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2019)

Systolic blood pressure and risk of valvular heart disease: A mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2019)

Plasma lipids and risk of aortic valve stenosis: A Mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2020)

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
by: Nazarzadeh Larzjan, M, et al.
Published: (2021)

Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions
by: Canoy, D, et al.
Published: (2021)

The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
by: Nazarzadeh, M, et al.
Published: (2022)

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
by: Rahimi, K, et al.
Published: (2019)

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality
by: Rao, S, et al.
Published: (2023)

Measurement of blood pressure in people with atrial fibrillation
by: Clark, CE, et al.
Published: (2019)

Long-term exposure to elevated systolic blood pressure in predicting incident cardiovascular disease: evidence from large-scale routine electronic health records
by: Solares, JR, et al.
Published: (2019)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
by: Rao, S, et al.
Published: (2023)

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
by: Rahimi, K, et al.
Published: (2021)

Connexin Lateralization Contributes to Male Susceptibility to Atrial Fibrillation
by: Simon Thibault, et al.
Published: (2022-09-01)

Systolic blood pressure and cardiovascular risk in patients with diabetes: a prospective cohort study
by: Rao, S, et al.
Published: (2022)

Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requires further research
by: Canoy, D, et al.
Published: (2018)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
by: Mighiu, A, et al.
Published: (2017)

Atrial fibrillation and 24‐h ambulatory blood pressure pattern
by: Willem J. Verberk
Published: (2022-07-01)

Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation
by: Vivencio Barrios, et al.
Published: (2017-09-01)

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
by: Nazarzadeh, M, et al.
Published: (2022)

Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
by: Maria H. Mehlum, et al.
Published: (2019-03-01)

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
by: Canoy, D, et al.
Published: (2022)

Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022-01-01)

Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
by: Chen Fang, et al.
Published: (2022-04-01)

Modulation of atrial fibrillation susceptibility by gp91phox-containing NADPH oxidases
by: Mighiu, A
Published: (2018)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
by: Priit Pauklin, et al.
Published: (2021-08-01)

Effects of obstructive sleep apnea and atrial fibrillation on blood pressure variability
by: Yusuf Ziya Şener, et al.
Published: (2019-11-01)

Management of blood pressure in heart failure
by: Pinho-Gomes, A, et al.
Published: (2019)

Intensive blood pressure lowering and risk of diabetes: Friend or foe?
by: Nazarzadeh, M, et al.
Published: (2019)

Effects of Sex on the Susceptibility for Atrial Fibrillation in Pigs with Ischemic Heart Failure
by: Valerie Pauly, et al.
Published: (2023-03-01)

Overview of programmed electrical stimulation to assess atrial fibrillation susceptibility in mice
by: Matthew B. Murphy, et al.
Published: (2023-04-01)

Subclinical atrial fibrillation in need of more assertive evidence
by: Rahimi, K
Published: (2017)

Atrial Myopathy Underlying Atrial Fibrillation
by: Harold Rivner, et al.
Published: (2020-08-01)